TNF and otosclerosis: Local expression of the TNF-α factor in the otic capsule can trigger the inflammatory response and bone resorption seen in otosclerosis; therefore, local or systemic administration of TNF-α inhibitors may be an option for the medical management of otosclerosis and its associated sensorineural hearing loss [24].